Monthly Market Snapshot: January 2021

A monthly update on equity, fixed income, currency, and commodity markets.

Views expressed are those of the authors and are subject to change. Other teams may hold different views and make different investment decisions. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional or institutional investors only.

Equities

Global equities (-0.1%) declined slightly in January. Markets started the year supported by the bullish narratives surrounding vaccine optimism, central bank liquidity tailwinds, strong earnings growth expectations, and the potential for additional fiscal stimulus; however, equities fell sharply at the end of January amid stretched valuation and sentiment indicators, fears about the health and economic risks of virus mutations, and a large uptick in volatility sparked by a retail-driven short squeeze. The broadening rollout of vaccines and favorable news about new vaccine developments were overshadowed by the logistical challenges of distributing and administering the vaccines, particularly in Europe, where Pfizer-BioNTech and AstraZeneca announced production delays. Additionally, new virus mutations first discovered in the UK, South Africa, and Brazil raised concerns that existing vaccines may be less effective. Retail day traders coordinated on social-media platforms to cause a short squeeze that saddled major hedge funds with losses of nearly US$20 billion, inducing legal and regulatory scrutiny. US President Joe Biden unveiled a US$1.9 trillion coronavirus relief package that was met with resistance by Republicans, who subsequently proposed a smaller, more targeted package worth approximately
US$600 billion.

US

US equities (-1.0%) ended the month lower, with stocks declining sharply during the last week of January amid heightened volatility. A frenzy of day trading in dozens of heavily shorted stocks forced many hedge funds to unwind short positions and reduce their gross exposure, exacerbating pressure on the market. Concerns about lofty valuations, record equity inflows, and the swelling US budget deficit fueled anxiety about a potential bubble in some areas of the market. Despite these fears, demand for equities was supported by prominent themes such as resilient corporate earnings, easy monetary policy, and prospects for additional fiscal stimulus. Cash levels were the lowest in eight years and allocations to risk assets hit a 10-year high. Although more virulent COVID-19 variants were discovered in the US, new infections receded from recent highs amid the sluggish (but accelerating) rollouts of vaccines. The Democrats secured slim majorities in both houses of Congress after winning control of the Senate, bolstering President Biden’s prospects of advancing his legislative agenda and increasing the likelihood of…

To read more, please click the download link below.

RECOMMENDED FOR YOU

<span>Top of Mind</span> Never assume and other tips for 2021
Multi-Asset Strategist Adam Berger stress tests the consensus views on four key issues: rising interest rates, high equity valuations, US market leadership, and the impact of slower globalization on China's growth.
February 2021
Top of Mind Never assume and other tips for 2021
,
From globalization to a “zero-sum” game
Globalization has increasingly begun to backpedal amid rising populism and a renewed emphasis on global competition over cooperation. Fixed Income Portfolio Manager John Soukas and Investment Director Chris Doherty discuss the implications and the role of active management in this shifting landscape.
February 2021
From globalization to a “zero-sum” game
,
Rewriting the recovery playbook
Multi-Asset Strategist Nick Samouilhan and Investment Directors Andrew Sharp-Paul and Matthew Bullock outline a proposed new playbook for navigating an economic recovery unlike any other.
January 2021
Rewriting the recovery playbook
,
A new inflationary regime: Why the next decade could look different from the last
We explore why the risk of structurally higher inflation may be the highest it has been in decades and profile the key investment implications this presents.
January 2021
A new inflationary regime: Why the next decade could look different from the last
,
Surviving the stress test: Companies adjusting to the new landscape
The pandemic has forced companies around the world to revisit their business plans and processes. Michael Carmen, co-head of Private Investments, moderates a discussion with three CEOs about how they have been navigating this time of crisis.
January 2021
Surviving the stress test: Companies adjusting to the new landscape
,
Taking the mystery out of multi-asset credit investing
Perhaps the most confounding question of all: How does one even measure “success” in such a heterogeneous investment realm? Fixed Income Investment Directors Anand Dharan and Amar Reganti lay out a robust framework for doing so.
January 2021
Taking the mystery out of multi-asset credit investing
,
Global ESG Research Update — Wellington joins Net Zero Asset Managers initiative
We explain our decision to join the Net Zero Asset Managers initiative as a founding member. We also provide an update on our ESG engagement and proxy voting activity in the quarter.
January 2021
Global ESG Research Update — Wellington joins Net Zero Asset Managers initiative
,
Four forces that could turn the tide for US financial stocks
US Macro Strategist Juhi Dhawan lays out a case for a better performing US financial sector, from attractive valuations to a steeper yield curve, as well as the role of Fed and fiscal policy in shaping the outcome.
January 2021
Four forces that could turn the tide for US financial stocks
,